Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/1996
10/09/1996EP0736038A1 Compounds with growth hormone releasing properties
10/09/1996EP0736032A1 Heterocyclic compounds
10/09/1996EP0736029A1 Anticonvulsant pseudofructopyranose sulfamates
10/09/1996EP0736028A1 Indoline derivatives, method of preparation and their use as pharmaceuticals
10/09/1996EP0736026A1 New pyridazino 4',5':3,4]pyrrolo- 2,1-a]isoquinolines and their use for preparing pharmaceutical compositions
10/09/1996EP0736025A1 Dyhydrobenzofuranyl-biphenyl carboxamides having 5ht 1d? antagonistic activity
10/09/1996EP0736024A1 N-heterobicyclyl-piperazinyl or-piperadinyl tricyclic derivatives useful as dopamine receptor ligands
10/09/1996EP0736023A1 Indole, indoline and quinoline derivatives with 5ht 1d? (anti-depressive) activity
10/09/1996EP0736020A1 6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
10/09/1996EP0736012A1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations
10/09/1996EP0736011A1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations
10/09/1996EP0736009A1 N-oxides of 4-arylpiperazines and 4-arylpiperidines as antipsychotic drugs
10/09/1996EP0736007A1 Non-peptide tachykinin receptor antagonists
10/09/1996EP0736004A1 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceuticals
10/09/1996EP0735894A1 Composition and methods to improve neural outcome
10/09/1996EP0735888A1 Purine compositions and methods for administration
10/09/1996EP0735872A1 A method of treating neurogenic inflammation
10/09/1996EP0735870A1 Use of pla 2? inhibitors as treatment for alzheimer's disease
10/09/1996EP0735821A1 Methods for the treatment or prevention of conditions associated with amyloidogenic reptides
10/09/1996EP0678089B1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders
10/09/1996EP0678088B1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders
10/09/1996CN1133047A Therapeutic peptide derivatives
10/09/1996CN1133045A 7-azabicyclo-|2,2,1¨-heptane and-heptene derivatives as analgesics and anti-inflammatory agents
10/09/1996CN1133044A Antipsychotic method
10/09/1996CN1133043A Bicyclic aromatic compounds as therapeutic agents
10/09/1996CN1133042A Indole derivatives as NMDA antagonists
10/09/1996CN1133012A Pharmaceutical formulations of nerve growth factor
10/09/1996CN1133010A Analgesic agent and its use
10/09/1996CN1133009A Levobupivacaine useful for managing chronic pain
10/09/1996CN1133008A Antipsychotic method
10/09/1996CN1132607A Fortified fruit juices
10/09/1996CN1032951C Tortoise and soft-shelled turtle composition and its prep.
10/08/1996US5563272 5,6-dihydro-4H-imidazo[4,5,1-IJ]quinolines
10/08/1996US5563164 Treating arthritis, psoriasis, asthma, inflammatory bowel disease, or alzheimer's disease
10/08/1996US5563160 N-cyano-N'-pyridylguanidines as serotonin antagonists
10/08/1996US5563157 Excitatory amino acid antagonists
10/08/1996US5563144 Antiserotonins, their preparation and pharmaceutical compositions containing them
10/08/1996US5563143 Antiinflammatory agents, autoimmune disorders
10/08/1996US5563140 Use of 1-(aminoalkyl)-3-(benzyl)-quinoxaline-2-one derivatives for the preparation of neuroprotective compositions
10/08/1996US5563136 3-Ureidobenzodiazepinones useful as antagonists of CCK or of gastrin
10/08/1996US5563134 Pharmaceutical compositions comprising clozapine and a radical scavenger
10/08/1996US5563131 Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
10/08/1996US5563048 Human stromal derived factor 1α and 1β, and DNAs encoding the same
10/08/1996US5562908 Treatment of sinus headache
10/08/1996CA2093048C Benzo¢b!thiophen-5-yl derivative and process for producing the same
10/08/1996CA2051697C Heterocyclic amines having central nervous system activity
10/04/1996CA2173305A1 Pyrazolidine derivative, radical scavenger, brain-infarction depressant, and brain-edema depressant
10/03/1996WO1996030766A1 Inhibition of tau-tau-association
10/03/1996WO1996030762A1 Insulin mimetic and enhancer assay
10/03/1996WO1996030406A1 Human g-protein coupled receptors
10/03/1996WO1996030375A1 Process and crystal forms of 2-methyl-thieno-benzodiazepine
10/03/1996WO1996030366A1 Polymorphs a and b of 1-(diphenylmethyl)-4-[3-(2-phenyl-1,3-dioxolan-2-yl) propyl]piperazine
10/03/1996WO1996030364A1 Pharmaceutical compositions
10/03/1996WO1996030339A1 Pyrrolidinyl hydroxamic acid compounds and their production process
10/03/1996WO1996030333A1 Bicyclic amine derivatives and their use as anti-psychotic agents
10/03/1996WO1996030056A1 Hydroxyalkyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
10/03/1996WO1996030049A2 Hapten-carrier conjugates for use in drug-abuse therapy
10/03/1996WO1996030048A1 Protein kinase c inhibitors
10/03/1996WO1996030007A1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
10/03/1996WO1996030000A1 Pharmaceutical composition for transdermic delivery
10/03/1996WO1996029995A1 Oral 2-methyl-thieno-benzodiazepine formulation
10/03/1996WO1996026196A3 Benzylpiperidines and piperazines as muscarinic antagonists
10/03/1996CA2770491A1 Hapten-carrier conjegates for use in drug-abuse therapy
10/03/1996CA2216806A1 Insulin mimetic and enhancer assay
10/03/1996CA2215833A1 Hydroxyalkyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
10/02/1996EP0735038A1 Protein kinase C inhibitors
10/02/1996EP0735024A1 Antidepressant N-(Heteroarylaminoalkyl)-4-napthyl substituted piperidines and tetrahydroperidines
10/02/1996EP0734439A1 p53-BINDING POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME
10/02/1996EP0734385A1 Substituted 2-carboxyalkyl-3-(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging agents for neurodegenerative disorders
10/02/1996EP0734384A1 3-substituted 1-arylindole compounds
10/02/1996EP0734381A1 Morpholine and thiomorpholine tachykinin receptor antagonists
10/02/1996EP0734379A1 Novel 2-arylalkenyl-azacycloalkane derivatives as sigma receptor ligands, preparation method therefor and therapeutical use thereof
10/02/1996EP0734378A1 Aminosulphonyl-phenyl-1h-pyrrole derivatives, method of their preparation and their use
10/02/1996EP0734376A1 Vitamin d amine and amide derivatives
10/02/1996EP0734374A1 N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid derivatives as chelating agents
10/02/1996EP0734262A1 Use of pentoxifyllin in the treatment of multiple sclerosis
10/02/1996EP0734260A1 Paroxetine tablets and process to prepare them
10/02/1996EP0734259A1 Antipsychotic method
10/02/1996EP0734256A1 Di-tert-butylphenol compounds useful as anti-inflammatory agents
10/02/1996EP0527975B1 Codeinone derivatives and their pharmaceutical use
10/02/1996EP0485578B1 Neurotropic growth factors comprising a homeobox peptide
10/02/1996DE19513040A1 Neue Borneolester, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung New Borneo Lester, processes for their preparation and their pharmaceutical use
10/02/1996CN1132510A Hydroisoquinoline derivatives
10/02/1996CN1132508A Piperazine derivatives
10/02/1996CN1132504A Inhibitor of inhibiting generation of beta-amyloid
10/02/1996CN1132206A Pyrrole derivatives
10/02/1996CN1132202A New benzopyran derivatives, their process of preparation and pharmaceutical compositions which contain them
10/02/1996CN1132072A NK-1 receptor antagonists for treatment of neuronal injury and stroke
10/01/1996US5561234 1-(7-chloroquinolin-4-yl)pyrazole-3-carboxamide N-oxide derivatives, method of preparing them, and their pharmaceutical compositions
10/01/1996US5561233 Process for the preparation of an intermediate of a benzo[a]quinolizinone derivative
10/01/1996US5561151 Antipyretic and analgesic methods of using optically pure R-etodolac
10/01/1996US5561150 Tricyclic pyrazole derivatives
10/01/1996US5561149 For nasal administration
10/01/1996US5561145 4-aryloxy- and 4-arylthiopiperidine derivatives
10/01/1996US5561144 (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
10/01/1996US5561135 N,N,N',N'-tetrasubstituted-1,2-ethanediamine derivative compounds
10/01/1996US5561132 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
10/01/1996US5561130 Azacyclic compounds
10/01/1996US5561113 Analgesics; antiiflammatory agents; gastrointestinal, urogenital and nervous system(cns) disorders; asthma; antiallergens
10/01/1996US5560935 Administering to inhibit plasma kallikrein production: improves peripheral blood flow, exhibits analgesic, antiinflammatory and antiallergic properties
1 ... 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 ... 1833